Advertisement

Index by author

October 01, 1995; Volume 275,Issue 1

  1. Gaginella, T S

    1. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
      B S Tsai, R H Keith, W E Perkins, R E Walsh, C P Anglin, P W Collins, A W Gasiecki, R F Bauer, P H Jones and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 368-373;

  2. Galan, A I

    1. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats.
      E Fernández, A I Galán, D Morán, J M González-Buitrago, M E Muñoz and R Jiménez
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 442-449;

  3. Gasiecki, A W

    1. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
      B S Tsai, R H Keith, W E Perkins, R E Walsh, C P Anglin, P W Collins, A W Gasiecki, R F Bauer, P H Jones and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 368-373;

  4. Gekle, M

    1. Time- and concentration-dependent biphasic effect of ochratoxin A on growth of proximal tubular cells in primary culture.
      M Gekle, C A Pollock and S Silbernagl
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 397-404;

  5. Gellai, M

    1. Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.
      M Gellai, M Jugus, T Fletcher, P Nambi, E H Ohlstein, J D Elliott and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 200-206;

  6. Giacobini, E

    1. Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
      G Cuadra and E Giacobini
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 228-236;

  7. Gianoulakis, C

    1. Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats.
      J P de Waele, K Kiianmaa and C Gianoulakis
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 518-527;

  8. Gonzalez-buitrago, J M

    1. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats.
      E Fernández, A I Galán, D Morán, J M González-Buitrago, M E Muñoz and R Jiménez
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 442-449;

  9. Goodman, M

    1. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
      T L Yaksh, A B Malmberg, S Ro, P Schiller and M Goodman
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 63-72;

  10. Graham, M J

    1. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides.
      R M Crooke, M J Graham, M E Cooke and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 462-473;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement